Making Drug Treatment Work: Opportunities and Challenges towards an Evidence- and Rights-Based Approach

Compulsory drug detention centers (CDDCs) are common throughout Asia. However, medical treatments for substance use disorders, such as opioid agonist treatment (OAT), are generally unavailable in these settings. In this report, the authors compare the effectiveness of CDDCs with voluntary drug treat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Wegman, Martin P. (VerfasserIn)
Format: Elektronisch E-Book
Sprache:English
Veröffentlicht: Washington, D.C The World Bank 2018
Schriftenreihe:World Bank E-Library Archive
Online-Zugang:Volltext
Zusammenfassung:Compulsory drug detention centers (CDDCs) are common throughout Asia. However, medical treatments for substance use disorders, such as opioid agonist treatment (OAT), are generally unavailable in these settings. In this report, the authors compare the effectiveness of CDDCs with voluntary drug treatment centers (VTCs) offering OAT in Malaysia. Positive urine drug testing (UDT) after release confirmed opioid relapse in both groups. Specifically, the authors measure the timing of relapse, that is, the authors compare when patients that have been discharged from CDDCs and VTCs relapse to opioid. The authors conducted a study on opioid dependent individuals from Malaysian CDDCs and VTCs from August 2012 to September 2014. Baseline (at the starting point of the study) and semi-monthly behavioral assessments and UDTs were conducted for up to one year after release and discharge. Relapse rates between the groups were compared using advanced statistical analysis. Screening occurred in 168 CDDC attendees and 113 VTC in-patients, with 89 (CDDC), and 95 (VTC) of these individuals, respectively, having a baseline interview and at least one UDT. The authors found that opioid-dependent persons that have been released from CDDCs relapse to opioid use significantly faster than those from VTC services. This suggests the services provided by CDDCs have little role in the treatment of opioid use disorders
Beschreibung:1 Online-Ressource
DOI:10.1596/29964